CMS Hong Kong LLP is equipped to handle the full scope of life sciences and healthcare-related issues, ranging from complex regulatory issues, dispute resolution, IP, and corporate matters. The team is jointly led by Beijing-based Jonathan Chu, who heads the IP practice with expertise in transactions, litigation and patent prosecution relating to manufacturing, investments, as well as research and development. Nicolas Zhu has two decades of experience advising foreign hospitals, pharmaceutical, and medical device clients on corporate and commercial law, M&A and patent rights. Roxie Meng focuses on life science and healthcare-related due diligence, competition and dispute resolution matters, while Laila Lu advises on foreign direct investments, joint ventures and commercial issues.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The CMS China team is highly responsive, proactive, helpful and excellent in providing succinct and informative legal advice. Their expertise and knowledge in the life science and healthcare sectors is impressive. ’
‘Roxie Meng has been fantastic to deal with. She is always highly engaged and responsive, manages multiple client portfolios with ease and is very clear and concise in the legal advice she provides. She is a pleasure to work with and I would highly recommend her to any clients.’
Key clients
- Takeda Pharmaceutical Company Limited
- The Wellcome Trust
- UCL
- GlaxoSmithKline
- Tasly Holding Group Co.,Ltd
- Bayer
- Medtronic
- Eli Lilly
- Novartis
- Nestlé
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Jonathan Chu; Nicolas Zhu
Other key lawyers
Roxie Meng